Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Sharon Osbourne sparked surgery concern once again this week as she stepped out in LA on Wednesday with a noticeably more ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The new weight-loss drugs have created “a hope and optimism ... by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported a higher treatment ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...